Hyperfine shares surge 11.76% intraday after India approves Swoop MRI system for commercialization.

Hyperfine Inc. surged 11.76% during intraday trading following two key developments: regulatory approval of its Swoop portable MRI system in India and a record Q4 revenue increase. The India approval by CDSCO grants access to a market with significant unmet neuroimaging demand, enabling commercialization via a partnership with Radiosurgery Global. Simultaneously, the company reported $5.3 million in Q4 revenue, a 54% rise from Q3, driven by mainstream adoption of its next-gen Swoop System and Optive AI software. These events collectively reinforced Hyperfine’s growth trajectory, positioning the Swoop system as a scalable solution for accessible brain imaging while demonstrating operational progress amid ongoing cash burn reduction. The stock’s sharp intraday gain reflects optimism over expanded market access and improved financial performance.